A novel 4 Pillar model of lifestyle intervention reduces blood pressure in cardiovascular disease and maintains this after 1-year

被引：0
|
作者：
Olden, Sam [1 ]
Kandola, Gavinder [1 ]
机构：
[1] CP R, London, England
来源：
JOURNAL OF HUMAN HYPERTENSION | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
O-15
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [41] Adalimumab maintains long-term remission in moderately to severely active Crohn's disease after infliximab failure: 1-year follow-up of gain trial
    Panaccione, Remo
    Sandbom, William J.
    D'Haens, Geert
    Enns, Robert A.
    Wolf, Douglas C.
    Lomax, Kathleen G.
    Pollack, Paul F.
    GASTROENTEROLOGY, 2008, 134 (04) : A133 - A134
  • [42] Enhanced Reliability of Artificial Intelligence Survival Models to Predict 1-Year Survival After Kidney Transplant Using a Novel Combined Model
    Mohseni, S.
    Olang, O.
    Pourjafari, E.
    Sajadi, N.
    Abolghasemian, M.
    Rezaei, M.
    Samiezadeh, A.
    Ziaei, N.
    Alavinia, M.
    Sabet, A.
    Shafiee, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S736 - S736
  • [43] Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection
    Wadei, Hani M.
    Amer, Hatem
    Griffin, Matthew D.
    Taler, Sandra J.
    Stegall, Mark D.
    Textor, Stephen C.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2011, 5 (01) : 39 - 47
  • [44] Change in Cardiometabolic Risk Factors Associated With Magnitude of Weight Regain 3 Years After a 1-Year Intensive Lifestyle Intervention in Type 2 Diabetes Mellitus: The Look AHEAD Trial
    Berger, Samantha E.
    Huggins, Gordon S.
    McCaffery, Jeanne M.
    Jacques, Paul F.
    Lichtenstein, Alice H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (20):
  • [45] Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial
    Minschart, Caro
    Myngheer, Nele
    Maes, Toon
    De Block, Christophe
    Van Pottelbergh, Inge
    Abrams, Pascale
    Vinck, Wouter
    Leuridan, Liesbeth
    Driessens, Sabien
    Mathieu, Chantal
    Billen, Jaak
    Matthys, Christophe
    Laenen, Annouschka
    Bogaerts, Annick
    Benhalima, Katrien
    ECLINICALMEDICINE, 2024, 70
  • [46] APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
    Freedman, Barry I.
    Rocco, Michael V.
    Bates, Jeffrey T.
    Chonchol, Michel
    Hawfield, Amret T.
    Lash, James P.
    Papademetriou, Vasilios
    Sedor, John R.
    Servilla, Karen
    Kimmel, Paul L.
    Wall, Barry M.
    Pajewski, Nicholas M.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (04): : 713 - 720
  • [47] Antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease of 1-year and 3-year after percutaneous coronary intervention: a nationwide population-based study
    Lee, S. R.
    Jung, J. H.
    Choi, E. K.
    Lee, S. W.
    Kwon, S.
    Park, J. S.
    Han, K. D.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2930 - 2930
  • [48] Factors Influencing Rent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A clinical Trial Based on 1-Year Follow-Up
    Cheng, Gong
    Chang, Feng-jun
    Wang, Yi
    You, Peng-Hua
    Chen, Hai-chao
    Han, Wen-qi
    Wang, Jun-wei
    Zhong, Ni-er
    Min, Zhi-qian
    MEDICAL SCIENCE MONITOR, 2019, 25 : 240 - 247
  • [49] Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective study
    Boughanem, Hatim
    Ruiz-Limon, Patricia
    Pilo, Jesus
    Lisbona-Montanez, Jose Manuel
    Tinahones, Francisco J.
    Indias, Isabel Moreno
    Macias-Gonzalez, Manuel
    GUT MICROBES, 2023, 15 (02)
  • [50] Levels of presepsin and midregion-proadrenomedulin in septic patients with end-stage renal disease after cardiovascular surgery: 1-year follow up study
    Maravic-Stojkovic, V
    Lausevic-Vuk, L.
    Jovic, M.
    Filipovic, M.
    Milinovic, Bojic T.
    Stojkovic, B.
    Isenovic, R. E.
    Djukanovic, B.
    INFECTION, 2013, 41 : S33 - S33
12345